CAS RN: 21929-66-8
Z-HIS(BZL)-OH
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250730
1g / 5g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: >95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 21929-66-8
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
>95%
0
Out of Stock
Hong Kong
Inquiry
21929-66-8 / (2S)-3-(1-benzylimidazol-4-yl)-2-(phenylmethoxycarbonylamino)propanoic acid
Standard CAS: 21929-66-8
Multi CAS: No
Basic Information
copy
CAS
21929-66-8 copy
Multi CAS
No copy
Molecular Formula
C21H21N3O4 copy
Molecular Weight
379.400000 copy
Exact Mass
379.153206 copy
SMILES
C1=CC=C(C=C1)CN2C=C(N=C2)C[C@@H](C(=O)O)NC(=O)OCC3=CC=CC=C3 copy
InChI
InChI=1S/C21H21N3O4/c25-20(26)19(23-21(27)28-14-17-9-5-2-6-10-17)11-18-13-24(15-22-18)12-16-7-3-1-4-8-16/h1-10,13,15,19H,11-12,14H2,(H,23,27)(H,25,26)/t19-/m0/s1 copy
InChIKey
RSDRIMXAOFFQMC-IBGZPJMESA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
28 copy
Aromatic heavy atom count
17 copy
Fraction Csp3
0.19 copy
Rotatable bonds
8 copy
H-bond acceptors
5 copy
H-bond donors
2 copy
Molar refractivity
102.66 copy
TPSA
93.45 copy
LogP / Solubility
WLOGP
2.85 copy
MLOGP
2.53 copy
XLogP3
2.7 copy
Consensus LogP
2.69 copy
Log S (ESOL)
-3.91 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-4.73 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-5.45 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-3.01 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
3 copy